Background: Observational epidemiologic studies have suggested that a low-sodium diet is associated with reduced mortality. Objective: The objective was to test the hypothesis that a higher dietary intake of sodium is associated with increased systemic inflammation-a potential risk factor for both cardiovascular disease and cancer. Design: The study design consisted of a randomly selected, crosssectional, population-based study of 2633 individuals surveyed in 1991, of whom 1597 participants provided paired urinary and blood samples permitting measurement of 24-h urinary sodium excretion and serum C-reactive protein (CRP) concentrations. Results: The mean (6SD) 24-h sodium intake for the population was 177 6 69 mmol. In the basic model adjusted for age, sex, and smoking, higher levels of 24-h sodium excretion were directly associated with serum CRP, with an increase in serum CRP of 1.20 mg/L per 100-mmol increment in sodium excretion (95% CI: 1.11, 1.30). However, this association was reduced after adjustment for body mass index, with an increase in serum CRP of 1.06 mg/L per 100-mmol increment in sodium excretion (95% CI: 21.02, 1.15). Conclusions: We observed a linear association between an objective measure of sodium intake and serum CRP that may be influenced by confounding by body mass index. The magnitude of these associations suggests that dietary sodium consumption is unlikely to be an important modifiable risk factor for increased systemic inflammation.
INTRODUCTION
A low-sodium diet is an established intervention for the prevention and treatment of hypertension (1) and may confer additional health benefits via other pathophysiological mechanisms. This hypothesis is supported by the observation that individuals who have a low intake of dietary sodium have a reduced mortality from all causes and from coronary heart disease, independent of established cardiovascular disease risk factors, including blood pressure (2) . Candidate mechanisms to explain this observation include effects on systemic inflammation, which is considered a risk factor for both cardiovascular disease (3) and cancer (4) . Because the best measure of dietary sodium intake is 24-h urinary excretion, very few large epidemiologic studies have been able to accurately assess the relation between sodium intake and systemic inflammation. We used data from a large population-based cross-sectional survey from 1991 to explore the association between the objective measures of 24-h urinary sodium excretion and systemic inflammation, evaluated on the basis of serum C-reactive protein (CRP) and how these associations may be modified by potential confounding factors, such as body mass index (BMI).
SUBJECTS AND METHODS

Study population
The study population and data collection methods were described in detail elsewhere (5, 6) . In summary, a sample of individuals aged 18-70 y was selected by systematic sampling from a random starting point in the local electoral register of a district of Nottingham in 1991. The aim of the original study was to study the associations between diet and lung disease, and no data on cardiovascular disease history or medication use were collected.
Data collection
Trained interviewers collected data on the participants, including self-reported smoking status in 3 categories: current smoker (those who had smoked a cigarette within 1 mo of the study), ex-smoker (those who had not smoked for 1 mo before participation), and never smokers. Data were collected on a variety of anthropometric measures, including weight and height, and a blood sample and 24-h urine samples were collected from those who consented to provide specimens. Written instructions were provided to optimize the accuracy of the 24-h urine collection and the self-report of the participant used to verify accuracy of 24-h urine collection; incomplete samples were discarded. After venesection, serum samples were separated by centrifugation within 15 min of collection and were stored at 280°C. Serum CRP was measured in 2005 by using a highly sensitive automated immunoturbidimetric assay on an Olympus AU5400 analyzer (Olympus UK, Watford, United Kingdom). The 24-h urinary sodium excretion was calculated by weighing returned specimens to estimate volume, and an aliquot was separated and sent for estimation of sodium concentrations by flame photometry. The investigation was approved by the University of Nottingham and Nottingham City Hospital Ethics committee.
Statistical analysis
Because visual inspection of the data showed that serum CRP was not normally distributed, we log transformed the data using the natural log function to create a new variable suitable for analysis using linear regression. The association of 24-h urinary sodium excretion with log serum CRP concentrations was explored by using a multiple linear model with adjustment for a priori confounding factors (ie, age, sex, smoking status, and smoking pack-year history). The effect of other exposures, including BMI (continuous variable), alcohol intake, social class using the 1990 UK Registrar General's classification, and Helicobacter pylori serological status (because it may be associated with systemic inflammation) were explored; these factors were added to the model if they resulted in a change in the size of association of .10%. To assess the linearity of the association between sodium excretion and log serum CRP, 24-h sodium excretion was categorized in quintiles, and linear regression models using the categorized or continuous measure of sodium were compared with the likelihood ratio test. Because the association between 24-h urinary sodium excretion and log serum CRP was linear, the data are presented in terms of the relation of 100-mmol increments of 24-h urinary sodium excretion with serum CRP. The analyses used the natural log transformation of serum CRP; however, to facilitate the presentation of the data and appreciation of the effect sizes, we present the results after having transformed these logged data back into the original units using the antilog transformation. Potential effect modification by these factors on the association between 24-h urinary sodium excretion and log serum CRP concentrations were also explored.
Because there is no clear definition of an elevated CRP concentration, we also used the 2 cutoff values of serum CRP (1 and 3mg/L) that were previously used in the Framingham Heart Study to define elevated concentrations, to explore the association of CRP with cardiovascular disease (7) in a secondary analysis. In all analyses, associations were considered significant if the P value was 0.05. All statistical analyses used STATA version 9 (STATA Corporation, College Station, TX).
RESULTS
In total, 2633 individuals provided data for the study, 1597 (61%) of whom provided a paired 24-h urinary sample and a blood sample ( Table 1 ). The inability of most of the 1036 individuals to provide paired biological samples was a consequence of their inability to provide a urine sample for analysis 1 Age (t test), smoking (chi-square analysis), log alcohol intake (t test), and log C-reactive protein (t test) were significantly different between the group who provided biological samples and those who did not, P , 0.05. There were no significant differences in sex (chi-square analysis), BMI (t test), socioeconomic status (chi-square analysis), or H. pylori status (chi-square analysis) between these 2 groups.
2 Mean 6 SD; n in brackets (all such values). 3 Median; interquartile range in parentheses and n in brackets (all such values). 4 Defined on the basis of the 1990 UK Registrar General's classification.
(n ¼ 931). Those who did not provide paired biological samples were younger than those who did provide samples (mean age: 41.2 compared with 46.5 y), were more likely to be smokers (P ¼ 0.001), were more likely to consume more alcohol (P ¼ 0.001), and had a higher log serum CRP concentration (P ¼ 0.006). Mean (6SD) 24-h sodium excretion in those who provided paired samples was 177 6 69 mmol. In the 1597 individuals who provided both urine and blood samples, 856 (54%) had a serum CRP concentration 1 mg/L, and 302 (19%) had a serum CRP 3mg/L. In the basic model adjusted for age, sex, and smoking ( Table  2) , higher levels of 24-h sodium excretion were associated with an elevated serum CRP concentration of 1.20 mg/L per 100-mmol increment in sodium intake (95% CI: 1.11, 1.30). However, this association was attenuated after adjustment for BMI, with an increase in serum CRP of 1.06 mg/L per 100-mmol increment in sodium intake (95% CI: 21.02, 1.15). These results were not appreciably changed by adjustment for the potential confounding factors socioeconomic status, alcohol intake, or H. pylori serological status. There was no significant effect modification of these associations by age, sex, or BMI divided into quartiles ( Table 3) .
In the secondary analysis, there was a strong association between 24-h urinary sodium excretion and the odds of having a serum CRP concentration 1 mg/L (odds ratio: 1.47 per 100-mL increment in sodium urinary excretion; 95% CI: 1.24, 1.74). This association was reduced after adjustment for BMI (odds ratio: 1.21 per 100-mmol increment in sodium urinary excretion; 95% CI: 1.01, 1.45). Analysis of the association between 24-h urinary sodium excretion and elevated serum CRP as defined by a measure 3 mg/L showed results similar to those from the above analysis (Table 2) , although the result ceased to be statistically significant after adjustment for BMI (odds ratio: 1.11 per 100-mmol increment in sodium urinary excretion; 95% CI: 0.90, 1.37).
DISCUSSION
Using data from a large randomly selected population-based cross-sectional study, we have reported for the first time that higher levels of 24-h urinary sodium excretion are at least in part associated with increased systemic inflammation and that this association may be a consequence of confounding by BMI. Our study was initiated as a consequence of the observation that a low-sodium diet is associated with a reduced mortality from both all causes and coronary heart disease, independent of established cardiovascular disease risk factors, including blood pressure (2) . This study population had a similar 24-h urinary sodium excretion to ours, with a median daily sodium intake of 205 mmol for men and 154 mmol for women as compared with our median daily sodium intake of 166 mmol.
One strength of our data was that they were based on a randomly selected population from the electoral register of a local authority area in Nottingham and were therefore likely to be representative of the general population. The population-based sampling permitted a wide range of sodium intakes to be studied, which enhanced the ability to consider how it related to systemic inflammation. The use of an objective measure of sodium intake was another strength of the study design, because dietary sodium is difficult to measure with other dietary epidemiologic tools, such as semiquantitative food-frequency questionnaires, although 24-h urinary sodium excretion measurements are still susceptible to measurement error, which we anticipated would have biased our results toward the null hypothesis. Storage of the serum samples at 280°C and the testing of the assays by the same individual in the same time period permitted confidence in the accuracy of the highly sensitive CRP assays. Those who donated a urine sample were generally similar to those who did not, except 4 Logistic regression analysis. that those who did not provide a sample in 1991 were slightly younger than those who did. Although this difference may have slightly modified the generalizability of these data, we do not believe that it altered the associations studied. One limitation of our data was the absence of detailed information on the presence of cardiovascular disease and the use of medications such as statins, which are known to modify systemic inflammation (8) . This was a reflection of the initial research question that led to these data being collected, which was to permit investigation of the association between sodium intake and lung disease. However, in the United Kingdom in 1991, the use of statins was generally limited to the treatment of hypercholesterolemia, and statins were not prescribed with the regularity that they are today. In fact, the higher prevalence of statins prescribed in the current practice of primary and secondary prevention of cardiovascular disease makes it unlikely that it would be possible to collect these data nowadays in a representative, randomly selected, population-based study.
Our data suggest that studies of sodium intake and systemic inflammation should consider BMI and other related measurements as potential confounding factors, because they are recognized to be risk factors for increased levels of systemic inflammation (9) However, we were unable to exclude the possibility that the use of multivariate regression to adjust for this effect may have actually resulted in an underestimation of the true association of dietary sodium intake with systemic inflammation and an overadjustment for the confounding effect of BMI because of the greater measurement error involved in measuring the former exposure compared with the latter (10) .
We are aware of only one previous published study of the effect of sodium intake on systemic inflammation, and this involved a relatively short period of manipulating dietary sodium intake. In this open, uncontrolled study, Nakandakare et al (11) studied the effects of consuming a diet of 160 mmol Na for 1 wk followed by a low-salt diet (60 mmol/d) for 3 wk on a variety of cardiovascular disease risk factors in 41 patients with hypertension. The fasting CRP concentration was reported to increase significantly from a mean value of 1.61-2.44 mg/L over this regimen. We also used 171 paired samples from a randomized placebocontrolled trial of a low-sodium diet (12) to assess the effect on changes in serum CRP. After eliminating the outlying values, we observed no effect over a 6-wk period, although the difference in sodium excretion between the 2 groups was only 43 mmol (AW Fogarty, unpublished observations, 2008). These observations are conflicting, which may have been due to the relatively small numbers of individuals studied or to differences in either the study designs or the decreases in sodium intake observed.
In summary, we report an association between higher 24-h sodium excretion and increased systemic inflammation that may be confounded by BMI, although we cannot exclude the possibility that the attenuation observed after adjustment for BMI represents an overadjustment due to differential measurement error. Future longitudinal studies of the effect of dietary sodium intake and health should consider adjusting for BMI, because this may be an important confounding factor, or using a randomized controlled trial study design. Regardless of the effect of a lowsodium diet on systemic inflammation, the benefits of a decrease in sodium intake on cardiovascular disease are compelling (13) (14) (15) .
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